Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Mesa Laboratories, Inc. MLAB
$156.42
-$3.73 (-2.38%)
На 18:01, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
856189126.00000000
-
week52high
226.40
-
week52low
114.21
-
Revenue
184335000
-
P/E TTM
-607
-
Beta
0.72560500
-
EPS
-0.29000000
-
Last Dividend
0.64000000
-
Next Earnings Date
25 мая 2023 г. в 12:00
Описание компании
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Evercore ISI Group | In-Line | Outperform | 04 янв 2021 г. |
| Keybanc | Sector Weight | 10 ноя 2020 г. | |
| JP Morgan | Neutral | 02 окт 2020 г. | |
| Jefferies | Buy | 04 дек 2019 г. | |
| Evercore ISI Group | Outperform | Outperform | 26 авг 2019 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Sakys John | D | 27702 | 2100 | 23 янв 2023 г. |
| Sakys John | D | 9696 | 2100 | 23 янв 2023 г. |
| Sakys John | A | 11796 | 2100 | 23 янв 2023 г. |
| Schmieder John Bradley | D | 68976 | 1571 | 13 янв 2023 г. |
| Schmieder John Bradley | D | 450 | 1000 | 13 янв 2023 г. |
| Schmieder John Bradley | D | 1450 | 571 | 13 янв 2023 г. |
| Schmieder John Bradley | A | 69547 | 571 | 13 янв 2023 г. |
| Hall Shannon | D | 957 | 230 | 08 дек 2022 г. |
| Sullivan John James | D | 42812 | 1425 | 28 ноя 2022 г. |
| Ladiwala Shiraz Shabanali | A | 40 | 40 | 15 ноя 2022 г. |
Новостная лента
Mesa Laboratories: Divisional Growth, Valuations Supportive Of Hold
Seeking Alpha
27 февр 2023 г. в 20:26
In Q3, Mesa Laboratories reported mixed results throughout the P&L with soft bottom-line fundamentals. FCF growth still lumpy with contraction in divisional growth.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Zacks Investment Research
14 февр 2023 г. в 10:32
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Is Mesa Labs (MLAB) a Solid Growth Stock? 3 Reasons to Think "Yes"
Zacks Investment Research
13 февр 2023 г. в 14:18
Mesa Labs (MLAB) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Mesa Labs (MLAB) Tops Q3 Earnings Estimates
Zacks Investment Research
06 февр 2023 г. в 11:17
Mesa Labs (MLAB) delivered earnings and revenue surprises of 11.90% and 5.95%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Mesa Laboratories' (MLAB) Q3 Earnings?
Zacks Investment Research
01 февр 2023 г. в 14:18
Continued strength in Mesa Laboratories' (MLAB) Clinical Genomics segment is expected to have driven up Q3 sales.